Veli‐Matti Leppänen

4.8k total citations · 1 hit paper
53 papers, 3.5k citations indexed

About

Veli‐Matti Leppänen is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Veli‐Matti Leppänen has authored 53 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Oncology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Veli‐Matti Leppänen's work include Angiogenesis and VEGF in Cancer (20 papers), Lymphatic System and Diseases (18 papers) and Cell Adhesion Molecules Research (6 papers). Veli‐Matti Leppänen is often cited by papers focused on Angiogenesis and VEGF in Cancer (20 papers), Lymphatic System and Diseases (18 papers) and Cell Adhesion Molecules Research (6 papers). Veli‐Matti Leppänen collaborates with scholars based in Finland, United States and Switzerland. Veli‐Matti Leppänen's co-authors include Kari Alitalo, Michael Jeltsch, Pipsa Saharinen, Sinem Karaman, Andrey Anisimov, Nisse Kalkkinen, Märt Saarma, Riikka Kivelä, Adrian Goldman and Denis Tvorogov and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Veli‐Matti Leppänen

52 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role and regulation of integrins in cell migration and invasion

2024 50 citations Megan Chastney, Veli‐Matti Leppänen et al. Nature Reviews Molecular Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veli‐Matti Leppänen Finland	30	1.7k	892	600	392	359	53	3.5k
Peter S. Choi United States	27	2.4k 1.4×	316 0.4×	604 1.0×	310 0.8×	400 1.1×	45	4.3k
Eleni Nikolakaki Greece	22	4.0k 2.4×	864 1.0×	460 0.8×	679 1.7×	637 1.8×	48	5.4k
Renate B. Pilz United States	39	2.6k 1.5×	396 0.4×	244 0.4×	340 0.9×	293 0.8×	102	4.2k
Ping Chi United States	35	2.8k 1.7×	1.1k 1.2×	605 1.0×	488 1.2×	494 1.4×	145	5.9k
Mario Encinas Spain	29	2.0k 1.2×	402 0.5×	780 1.3×	343 0.9×	345 1.0×	49	3.4k
Hong‐Duk Youn South Korea	36	3.0k 1.8×	530 0.6×	351 0.6×	182 0.5×	747 2.1×	86	3.9k
Ying Jin China	32	1.6k 0.9×	254 0.3×	388 0.6×	319 0.8×	372 1.0×	100	3.0k
Tommaso Mello Italy	34	1.3k 0.8×	471 0.5×	282 0.5×	245 0.6×	340 0.9×	90	3.4k
Christoph Harms Germany	34	1.6k 1.0×	415 0.5×	516 0.9×	163 0.4×	261 0.7×	80	3.3k
Junhua Yang United States	29	1.6k 0.9×	678 0.8×	363 0.6×	167 0.4×	300 0.8×	80	2.8k

Countries citing papers authored by Veli‐Matti Leppänen

Since Specialization

Citations

This map shows the geographic impact of Veli‐Matti Leppänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veli‐Matti Leppänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veli‐Matti Leppänen more than expected).

Fields of papers citing papers by Veli‐Matti Leppänen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veli‐Matti Leppänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veli‐Matti Leppänen. The network helps show where Veli‐Matti Leppänen may publish in the future.

Co-authorship network of co-authors of Veli‐Matti Leppänen

This figure shows the co-authorship network connecting the top 25 collaborators of Veli‐Matti Leppänen. A scholar is included among the top collaborators of Veli‐Matti Leppänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veli‐Matti Leppänen. Veli‐Matti Leppänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brouillard, Pascal, Aino Murtomäki, Veli‐Matti Leppänen, et al.. (2024). Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. Journal of Clinical Investigation. 134(14). 2 indexed citations

Chastney, Megan, et al.. (2024). The role and regulation of integrins in cell migration and invasion. Nature Reviews Molecular Cell Biology. 26(2). 147–167. 50 indexed citations breakdown →

Fang, Shentong, Shuo Chen, Harri Nurmi, et al.. (2020). VEGF-C protects the integrity of the bone marrow perivascular niche in mice. Blood. 136(16). 1871–1883. 44 indexed citations

Lähde, Marianne, Seppo Kaijalainen, Andrey Anisimov, et al.. (2020). Expression of R-Spondin 1 in Apc Mice Suppresses Growth of Intestinal Adenomas by Altering Wnt and Transforming Growth Factor Beta Signaling. Gastroenterology. 160(1). 245–259. 32 indexed citations

Crona, Daniel J., Andrew D. Skol, Veli‐Matti Leppänen, et al.. (2018). Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib. Cancer Research. 79(1). 231–241. 25 indexed citations

Kallio, Pauliina, Marianne Lähde, Veli‐Matti Leppänen, et al.. (2018). Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem–like Cells. Cancer Research. 78(20). 5820–5832. 22 indexed citations

Jha, Sawan Kumar, Terhi Kärpänen, Veli‐Matti Leppänen, et al.. (2017). Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific Reports. 7(1). 4916–4916. 66 indexed citations

Saharinen, Pipsa, Veli‐Matti Leppänen, & Kari Alitalo. (2017). SnapShot: Angiopoietins and Their Functions. Cell. 171(3). 724–724.e1. 21 indexed citations

Sipilä, Tuomas, Veli‐Matti Leppänen, Prson Gautam, et al.. (2015). Endothelial destabilization by angiopoietin-2 via integrin β1 activation. Nature Communications. 6(1). 5962–5962. 213 indexed citations

10.

Raissadati, Alireza, S. Syrjälä, Georgia Zarkada, et al.. (2015). Ischemia–Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. American Journal of Transplantation. 16(4). 1160–1172. 37 indexed citations

11.

Jeltsch, Michael, Sawan Kumar Jha, Denis Tvorogov, et al.. (2014). CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation. Circulation. 129(19). 1962–1971. 178 indexed citations

12.

Anisimov, Andrey, Denis Tvorogov, Annamari Alitalo, et al.. (2013). Vascular Endothelial Growth Factor-Angiopoietin Chimera With Improved Properties for Therapeutic Angiogenesis. Circulation. 127(4). 424–434. 48 indexed citations

13.

Kisko, Kaisa, Maurice S. Brozzo, J. Missimer, et al.. (2011). Structural analysis of vascular endothelial growth factor receptor‐2/ligand complexes by small‐angle X‐ray solution scattering. The FASEB Journal. 25(9). 2980–2986. 33 indexed citations

14.

Tvorogov, Denis, Andrey Anisimov, Wei Zheng, et al.. (2010). Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization. Cancer Cell. 18(6). 630–640. 99 indexed citations

15.

Lindholm, Päivi, Merja H. Voutilainen, Juha Laurén, et al.. (2007). Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature. 448(7149). 73–77. 349 indexed citations

16.

Yang, Jing, Pia Runeberg‐Roos, Veli‐Matti Leppänen, & Märt Saarma. (2007). The mouse soluble GFRα4 receptor activates RET independently of its ligand persephin. Oncogene. 26(26). 3892–3898. 11 indexed citations

17.

Lehtiö, L., Veli‐Matti Leppänen, John W. Kozarich, & Adrian Goldman. (2002). Structure ofEscherichia colipyruvate formate-lyase with pyruvate. Acta Crystallographica Section D Biological Crystallography. 58(12). 2209–2212. 15 indexed citations

18.

Leppänen, Veli‐Matti, et al.. (1999). Sulfolobus acidocaldarius inorganic pyrophosphatase: Structure, thermostability, and effect of metal ion in an archael pyrophosphatase. Protein Science. 8(6). 1218–1231. 26 indexed citations

19.

Ollikka, Pauli, et al.. (1993). Decolorization of Azo, Triphenyl Methane, Heterocyclic, and Polymeric Dyes by Lignin Peroxidase Isoenzymes from Phanerochaete chrysosporium. Applied and Environmental Microbiology. 59(12). 4010–4016. 260 indexed citations

20.

Karvonen, M. J., Veli‐Matti Leppänen, & Marja Pitkänen. (1953). The effect of pituitrin, pitressin, and pitocin on urinary sodium and potassium excretion in dog.. PubMed. 31(2). 117–23. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact